The 20 Best Acute Lymphoblastic Leukemia (ALL) Doctors Near Me in District of Columbia, US

Anne Angiolillo is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Angiolillo is rated as an Elite provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Febrile Neutropenia, and Immune Thrombocytopenic Purpura (ITP).

Reuven Schore, MD, is a pediatric oncologist and a member of the Leukemia/Lymphoma Program at Children's National Hospital. Dr. Schore is an associate professor, pediatrics at George Washington University School of Medicine. Dr. Schore is the vice chair for a Children's Oncology Group study investigating intravenous treatments for patients with high-risk acute lymphoblastic leukemia (ALL). Dr. Schore is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Juvenile Myelomonocytic Leukemia (JMML), and Febrile Neutropenia. Dr. Schore is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2006 and Pediatrics: American Board Of Pediatrics, 2003.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Bhupender Yadav is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 26 years. Dr. Yadav is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His clinical expertise encompasses Hirschsprung Disease, Lymphangiomatosis, Pneumomediastinum, and Congenital Athymia. Dr. Yadav is board certified in Pediatric Radiology: American Board Of Radiology, 2013, Diagnostic Radiology: American Board Of Radiology, 2011, and American Board Of Radiology, 2011.

Xiaojun Wu, M.D., Ph.D. is as assistant professor of pathology at Sibley Memorial Hospital where she will lead their hematopathology program. Dr. Wu received her M.D. from Zhejiang Medical University in China, and her Ph.D. from the University of Alabama at Birmingham. She continued at the University of Alabama at Birmingham for pathology residency training, followed by a fellowship in hematopathology. She then moved to New York where she completed a surgical pathology fellowship at Memorial Sloan Kettering Cancer Center. She subsequently joined the faculty at New York University from 2013-2015 and moved to the Washington area in 2015 and joined the faculty at George Washington University from 2015-2016. She has been with Johns Hopkins since 2016. Dr. Wu has 15 peer-reviewed publications, primarily in the field of hematopathology. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Acute Myeloid Leukemia (AML). Dr. Wu is board certified in American Board Of Pathology.

Narendra Shet is a Pediatric Radiologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 19 years. Dr. Shet is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Atresia of Small Intestine, Scoliosis, Short Stature (Growth Disorders), and Situs Inversus. Dr. Shet is board certified in Pediatric Radiology: American Board Of Radiology, 2015 and Diagnostic Radiology: American Board Of Radiology, 2012.

Ramon Sanchez is a Pediatric Radiologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 33 years. Dr. Sanchez is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Hirschsprung Disease, Scoliosis, Caudal Regression Syndrome, and Spondylocarpotarsal Synostosis Syndrome. Dr. Sanchez is board certified in Pediatric Radiology: American Board Of Radiology, 2014 and Diagnostic Radiology: American Board Of Radiology, 2012.

Eglal Shalaby-Rana, MD, is a radiologist in the Division of Diagnostic Imaging and Radiology at Children's National Hospital. She is the director of performance improvement. Dr. Rana is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Hirschsprung Disease, Scoliosis, Knock Knees, and Biliary Atresia. Dr. Rana is board certified in Pediatric Radiology: American Board Of Radiology, 1995 and Diagnostic Radiology: American Board Of Radiology, 1987.

Nita L. Seibel, MD, is a board-certified pediatrician and pediatric hematologist-oncologist. After graduating from the Ohio State University College of Medicine in 1988, she completed her internship and residency at the Ohio State University Children’s Hospital in 1984. Dr. Seibel completed a fellowship in pediatric hematology-oncology at the Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health in 1987. She joined the faculty of Children's National Hospital in 1988 and is a professor of pediatrics at the George Washington University School of Medicine & Health Sciences. While at Children's National, Dr. Seibel has served for over 15 years on the Institutional Review Board, as Director of the Hematology/Oncology Training Program for nine years and as Principal Investigator for Children's Oncology Group. Dr. Seibel has chaired numerous studies for the Children’s Oncology Group including chairing the Phase I Data Safety Monitoring Committee and served as vice-chair for Phase I agents. Dr. Seibel was also a member of the National Wilms Tumor Study and later the COG Renal Tumor Committee. Dr. Seibel's areas of special interest are: Wilms tumor, bone tumors, ALL, and adolescent and young adult oncology as well as late effects. She also has a special interest in Acute Lymphoblastic Leukemia in adolescents and young adults and anti-fungal agents. Dr. Seibel is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult Soft Tissue Sarcoma, and Infantile Neutropenia. Dr. Seibel is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1987 and Pediatrics: American Board Of Pediatrics, 1986.

Catherine Bollard is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Bollard is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Graft Versus Host Disease (GvHD), Leukemia, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant.

Gregory Reaman is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Reaman is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Rhabdomyosarcoma, and Adult Soft Tissue Sarcoma.

Alexandra Dreyzin is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Dreyzin is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Hemophagocytic Lymphohistiocytosis, and Non-Langerhans-Cell Histiocytosis.

Jeffrey Dome, MD, PhD, is senior vice president of the Cancer and Blood Disorders Center at Children’s National Hospital in Washington, D.C. He is professor of pediatrics at the George Washington University School of Medicine and Health Sciences and the Thomas Willson and Lenore Williams McKnew professor of pediatric oncology. Dr. Dome received his medical degree from the University of Pennsylvania School of Medicine and PhD degree in medicine from Erasmus University in Rotterdam. He completed a residency in pediatrics at Yale-New Haven Hospital and completed a fellowship in pediatric hematology/oncology at Johns Hopkins Hospital. After fellowship, Dr. Dome was a faculty member at St. Jude Children’s Research Hospital before joining Children’s National in 2006. Dr. Dome is an internationally recognized expert on pediatric solid tumors, with an emphasis on kidney tumors and sarcomas. He chaired the Children’s Oncology Group (COG) Renal Tumor Committee for more than a decade. He is presently on the Scientific Council of the COG, the editorial board of Pediatric Blood and Cancer, and is past chair of the American Board of Pediatrics Subboard of Hematology/Oncology. Dr. Dome serves on numerous medical advisory boards for cancer foundations and currently is the North American Continental President of the International Society of Pediatric Oncology (SIOP). He has authored more than 200 articles, books, letters and chapters on pediatric cancer. Dr. Dome is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Rhabdoid Tumor, Denys-Drash Syndrome (DDS), Adult Soft Tissue Sarcoma, Nephrectomy, and Bone Marrow Aspiration. Dr. Dome is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1998.

Anant Vatsayan, MBBS, is a blood and marrow transplant/cellular therapy attending at Children’s National Hospital. He is an assistant professor of pediatrics at the George Washington School of Medicine and Health Sciences, the cellular therapy laboratory medical director, and the pediatric BMT fellowship director for the joint NCI/Children’s National Hospital BMT Fellowship Program. He is a board-certified pediatric hematologist/oncologist. Prior to joining Children’s National, Dr. Vatsayan completed a two-year fellowship in cellular therapy/blood and marrow transplantation (BMT) at Memorial Sloan Kettering Center, New York. He did his pediatric hematology/oncology fellowship at Rainbow Babies and Children’s Hospital, Case Western Reserve University, Cleveland, Ohio. His research interests include BMT/cellular therapies for pediatric high-risk hematologic malignancies. He is the clinical lead for the Chimeric Antigen Receptor T (CAR-T) therapy program at Children’s National. His other interests include novel transplantation techniques like TCR alpha/beta T cell depleted BMT, graft versus host disease and BMT for high-risk inherited bone marrow failure syndromes, like Fanconi anemia. Dr. Vatsayan is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His clinical expertise encompasses Non-Langerhans-Cell Histiocytosis, Hemophagocytic Lymphohistiocytosis, Acquired Amegakaryocytic Thrombocytopenia, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant. Dr. Vatsayan is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2017 and Pediatrics: American Board Of Pediatrics, 2013.

Hannah Kinoshita, MD, is an oncologist in the Division of Oncology in the Center for Cancer and Blood Disorders. Her research interests include cellular immunotherapy for high-risk hematologic malignancies. Dr. Kinoshita is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Acute Lymphoblastic Leukemia (ALL), Leukemia, Medulloblastoma, and Bone Marrow Transplant. Dr. Kinoshita is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2023 and American Board Of Pediatrics, 2018.

Jennifer Levine is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 27 years. Dr. Levine is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Malignant Peripheral Nerve Sheath Tumor, Febrile Neutropenia, and Medulloblastoma. Dr. Levine is board certified in American Board Of Pediatrics, 2006 and American Board Of Pediatrics, 2003.

David Jacobsohn, MD, ScM, MBA, is the division chief of the Blood and Marrow Transplantation Program at Children’s National Hospital and full professor of Pediatrics at the George Washington University. He leads a program of upwards of 70 pediatric transplants per year. The program performs transplants in patients with malignant and non-malignant conditions, and has expertise with all stem cell sources including haplo-identical transplants. His expertise is in graft-versus-host disease (GvHD) clinical trials: reducing incidence of GvHD as well as novel therapies for GvHD. He has more than 10 years of experience in clinical research in pediatric GvHD. His work has included the study of novel drugs for chronic GvHD, classification criteria for chronic GvHD, and risk factor stratification in pediatric chronic GvHD. He is active in the BMT community at a national level. Examples of some current and prior roles include head of the GVHD committee for the Pediatric Blood and Marrow Transplant Consortium, member-at-large of the that Consortium, member of the Children’s Oncology Group Stem Cell Transplant Committee, member of the Clinical Trials Network State of the Science Pediatric Advisory Group. Dr. Jacobsohn has been instrumental in growing the capabilities of the Blood and Marrow Transplant Program. For example, for the last five years the program is one of the few pediatric programs performing alpha/beta T cell depletion for haploidentical transplants. This novel method for GVHD prevention has significantly improved the outcome of haploidentical BMT at Children’s National. Additionally, he has been involved with the deployment of gene therapy for hemoglobinopathies. He successfully led Children’s National to become the first program in the country to collect stem cells for a commercial sickle cell gene therapy treatment. Dr. Jacobsohn is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Hemoglobinopathy, Anemia, Sickle Cell Disease, and Bone Marrow Transplant. Dr. Jacobsohn is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2002 and Pediatrics: American Board Of Pediatrics, 1999.

Holly Meany, MD, is a pediatric oncologist and director of the Solid Tumor Program at Children’s National Hospital. She also serves as an associate professor of pediatrics at George Washington University. Dr. Meany is dedicated to finding better treatments for children with cancer through research and clinical care. Her work focuses on developing new therapies for pediatric solid tumors. She designs and leads early-phase clinical trials to test promising treatments and understand how they work in children. Dr. Meany has played a key role in several national studies, including large trials for neuroblastoma, a type of childhood cancer. She recently led an international study for children with newly diagnosed non-high-risk neuroblastoma and is currently helping to develop the next high-risk neuroblastoma trial, both through the Children’s Oncology Group. Dr. Meany is also exploring innovative approaches like immunotherapy—using the body’s own immune system to fight cancer. She has led international studies using specialized T cells to treat patients with relapsed solid tumors and is now working on combining these novel T cells with CAR T-cell therapy for children with relapsed cancers. In addition to her research, Dr. Meany is passionate about training the next generation of pediatric cancer specialists. As director of the Pediatric Hematology-Oncology Fellowship Program at Children’s National, she mentors and supports future leaders in the field. Dr. Meany is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Hereditary Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Osteosarcoma, and Mastoidectomy. Dr. Meany is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2006 and Pediatrics: American Board Of Pediatrics, 2003.

Thomas Newton is a Pediatric Hematologist Oncology provider practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 30 years. Dr. Newton is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Sickle Cell Disease, Febrile Neutropenia, and Hemolysis. Dr. Newton is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009 and Pediatrics: American Board Of Pediatrics, 1999.

"Eugene (Gene) Hwang, MD, is chief of the Division of Oncology at Children’s National Hospital in Washington, D.C. He is also part of the Children's National Hospital pediatric neuro-oncology team, focusing on treating children with brain tumors. Dr. Hwang has developed and led many novel early phase therapeutic clinical trials with a focus on immunotherapeutic trials, and he also leads trials focused on gene therapy and new, targeted agents. He is the site Principal Investigator of the Pediatric Brain Tumor Consortium, where he is the co-chair of the Immunotherapy Working Group. He serves on grant review committees and on the scientific advisory boards of several large foundations. For each patient, Dr. Hwang carefully considers the best possible options for treatment, trying new, cutting edge treatments coupled with the best available known therapies. Dr. Hwang is not only dedicated to finding a cure for cancer, but also to making the current treatments as safe as possible for children: ""We often focus on curing the children - that's the number one goal - but we also need to pay attention to the toxicity of these treatments, and what quality of life the children will have after treatment."" Dr. Hwang is involved in several international efforts to study how to best mitigate treatment side effects. In the meantime, Dr. Hwang makes sure he is doing everything he can to combat pain, dizziness, fatigue and other common side effects of cancer treatments by leveraging the multidisciplinary team approach of Children's National. He sees this as something the organization does exceptionally well, and thinks that having so many people focus on a single patient in a single visit is crucial to well-being during cancer treatment.". Dr. Hwang is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pineocytoma, Glioma, Medulloblastoma, and Pineoblastoma. Dr. Hwang is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009 and Pediatrics: American Board Of Pediatrics, 2005.